Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study.
Täubel J, Hauke W, Rump S, Viereck J, Batkai S, Poetzsch J, Rode L, Weigt H, Genschel C, Lorch U, Theek C, Levin AA, Bauersachs J, Solomon SD, Thum T. Täubel J, et al. Among authors: batkai s. Eur Heart J. 2021 Jan 7;42(2):178-188. doi: 10.1093/eurheartj/ehaa898. Eur Heart J. 2021. PMID: 33245749 Free PMC article. Clinical Trial.
MicroRNA-based therapy in cardiology.
Fiedler J, Batkai S, Thum T. Fiedler J, et al. Among authors: batkai s. Herz. 2014 Mar;39(2):194-200. doi: 10.1007/s00059-013-4047-0. Herz. 2014. PMID: 24573748 Review.
Analytical approaches in microRNA therapeutics.
Batkai S, Thum T. Batkai S, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Aug 1;964:146-52. doi: 10.1016/j.jchromb.2014.03.027. Epub 2014 Apr 15. J Chromatogr B Analyt Technol Biomed Life Sci. 2014. PMID: 24908160 Review.
MicroRNAs in right ventricular remodelling.
Batkai S, Bär C, Thum T. Batkai S, et al. Cardiovasc Res. 2017 Oct 1;113(12):1433-1440. doi: 10.1093/cvr/cvx153. Cardiovasc Res. 2017. PMID: 28957533 Review.
Preclinical development of a miR-132 inhibitor for heart failure treatment.
Foinquinos A, Batkai S, Genschel C, Viereck J, Rump S, Gyöngyösi M, Traxler D, Riesenhuber M, Spannbauer A, Lukovic D, Weber N, Zlabinger K, Hašimbegović E, Winkler J, Fiedler J, Dangwal S, Fischer M, de la Roche J, Wojciechowski D, Kraft T, Garamvölgyi R, Neitzel S, Chatterjee S, Yin X, Bär C, Mayr M, Xiao K, Thum T. Foinquinos A, et al. Among authors: batkai s. Nat Commun. 2020 Jan 31;11(1):633. doi: 10.1038/s41467-020-14349-2. Nat Commun. 2020. PMID: 32005803 Free PMC article.
Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy.
Viereck J, Bührke A, Foinquinos A, Chatterjee S, Kleeberger JA, Xiao K, Janssen-Peters H, Batkai S, Ramanujam D, Kraft T, Cebotari S, Gueler F, Beyer AM, Schmitz J, Bräsen JH, Schmitto JD, Gyöngyösi M, Löser A, Hirt MN, Eschenhagen T, Engelhardt S, Bär C, Thum T. Viereck J, et al. Among authors: batkai s. Eur Heart J. 2020 Sep 21;41(36):3462-3474. doi: 10.1093/eurheartj/ehaa519. Eur Heart J. 2020. PMID: 32657324 Free PMC article.
137 results